Psychemedics Third Quarter 2024 Earnings: US$0.091 loss per share (vs US$0.36 loss in 3Q 2023)
Revenue: US$5.18m (down 9.3% from 3Q 2023). Net loss: US$535.0k (loss narrowed by 75% from 3Q 2023). US$0.091 loss per share ...
Psychemedics Reports Improved Losses Amid Revenue Dip
Psychemedics ( (PMD) ) has released its Q3 earnings. Here is a breakdown of the information Psychemedics presented to its investors.
Psychemedics: Q3 Earnings Snapshot
Psychemedics Corp. PMD) on Tuesday reported a loss of $500,000 in its third quarter. On a per-share basis, the Dallas-based company said it had a loss of 9 cents.
manilatimes2d
Runway Growth Finance Corp. Reports Third Quarter 2024 Financial Results
As of September 30, 2024, net asset value ("NAV”) per share was $13.39, compared to $14.08 as of September 30, 2023. Total net assets at the end of the third quarter was $507.4 million, down 11% from ...
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
DALLAS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the third quarter ending September 30, ...